VANCOUVER, British Columbia, April 01, 2026 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company” or “Cannabix”) developer of marijuana and alcohol breath testing devices for workplace safety and law enforcement, is pleased to announce the commercial delivery of its Marijuana Breath Test (“MBT”) products to a leading industrial manufacturing company with operations in the state of Virginia. The delivery was completed through an authorized reseller. The announcement highlights diverse industries that are adopting the Company’s non-invasive breath-based testing products to support workplace safety programs.
The client, which operates large-scale custom machinery fabrication, sought a scientifically grounded method to assess recent cannabis use among its workforce amid growing concerns about THC-related safety incidents and the limitations of traditional drug testing.
Manufacturing Sector Faces Rising Cannabis-Related Safety Pressures
Industrial manufacturing environments—particularly those involving production lines, machining, robotics, welding, electrical systems, and material-handling equipment—are among the most safety-sensitive workplaces in the U.S. Employers across the sector report increasing challenges related to cannabis use, including:
-
Higher rates of workplace injuries associated with safety-relevant reaction time and reduced situational awareness
-
Labor shortages, making it difficult to suspend or replace employees based solely on legacy drug tests
-
Outdated testing methods (urine, saliva) that detect cannabis exposure from days or weeks prior
-
Legal and policy conflicts resulting from state-level legalization of recreational and medical marijuana
-
Insurance and compliance pressures requiring clearer documentation of safety-relevant testing
Manufacturing employers are especially impacted because they operate heavy equipment, must maintain strict safety programs, and cannot rely on drug tests that fail to distinguish recent cannabis use from historical use.
MBT: A Modern, Non-invasive Tool for Detecting Recent Cannabis Use
The Cannabix MBT system is designed to detect delta-9 THC—the primary psychoactive compound in cannabis—in breath within four hours of use, at levels above 5 pg/L. This short detection window aligns closely with the period most correlated with recent-use effects, offering a valuable alternative to legacy drug tests that identify past consumption. The MBT includes Cannabix’s proprietary Breath Collection Unit and Breath Cartridge technologies (see Figure 1) to collect and preserve breath samples for laboratory analysis using gold-standard liquid chromatography-mass spectrometry (LC-MS) methods. This window aligns closely with recent-use timeframes, offering an actionable alternative to legacy tests that detect past exposure.
